Asia is home to 60% of the world’s population, and by 2030, one in four people in the region will be aged over 60. This demographic shift will significantly increase the need for diagnosis, treatment, and management of chronic conditions such as cardiovascular disease, diabetes, cancer, and neurodegenerative disorders.
The impact on healthcare systems will be considerable:
- Growing demand for early detection technologies, minimally invasive procedures, and home-based monitoring solutions.
- Increased pressure on supply chains to provide reliable and cost-effective medical devices.
- Greater emphasis on cross-border regulatory collaboration to accelerate access to essential innovations.
Already the second-largest MedTech market globally, Asia’s sector is projected to grow at 10.5% annually until 2030. Markets such as China, India, Japan, and ASEAN are emerging as global hubs for both manufacturing and innovation, supported by substantial investment in healthcare infrastructure and digital health transformation.
For manufacturers, this is more than a positive market outlook. It is a strategic opportunity to establish a strong presence by understanding local regulatory requirements, adapting products to meet regional needs, and forming trusted partnerships in target markets. Companies that act now will be well positioned to capture the growing demand and strengthen their leadership in the region.
Get in touch with our experts for a streamlined market entry.
